Abstract
Medullary thyroid carcinoma (MTC) is a rare form of malignancy, having an intermediate prognosis. Controversies exist regarding the best surgical approach. The aim of the study was to analyze the outcome in a group of patients with MTC, diagnosed and followed up in a single care center. We performed a retrospective analysis of all the patients diagnosed with MTC in the Department of Endocrinology from the County Emergency Hospital Timisoara between 1992 and 2012. The study group included 19 patients, 6 men (31.6 %), mean age 41.2 ± 12.5 years (20–72 years). The preoperative diagnosis was based on the protocol for nodular thyroid disease. Total or near-total thyroidectomy was performed in 10 out of 16 patients who could be operated. Postoperative follow-up included repeated measurements of serum calcitonin and imaging investigations. Nine out of the total of 19 (47.3 %) patients had hereditary forms of MTC. Most of the cases (84.2 %) were submitted to surgery. The median duration of follow-up was 84 months. The pTNM staging indicated that the majority of the patients with hereditary MTC were diagnosed in an earlier stage. Disease remission was achieved in 7 cases (43.8 %). Four patients, all with sporadic forms, died. Survival rates at 1, 5 and 10 years were significantly higher (p = 0.048) in patients with hereditary MTC. An early diagnosis of MTC allows a better surgical approach and an improved survival rate. We support the general recommendation that modified radical neck dissection is not necessary for all the patients with MTC.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12262-015-1386-5/MediaObjects/12262_2015_1386_Fig1_HTML.gif)
Similar content being viewed by others
References
Matias-Guiu X, De Lellis R (2014) Medullary thyroid carcinoma: a 25-year perspective. Endocr Pathol 25:21–29. doi:10.1007/s12022-013-9287-2
Schlumberger MJ, Filetti S, Hay ID (2008) Nontoxic diffuse and nodular goiter and thyroid neoplasia. In: Kronenberg HM, Melmed S, Polonsky KS, Reed Larsen P (eds) Williams textbook of endocrinology, 11th edn. Saunders Elsevier, Philadelphia, pp 411–442
Grozinsky-Glasberg S, Benbassat CA, Tsvetov G, Feinmesser R, Hava Peretz H, Shimon I, Lapidot M (2007) Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005. Thyroid 17:549–556
American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565–612. doi:10.1089/thy.2008.0403
Schlumberger M, Bastholt L, Dralle H, Jarzab B, Pacini F, Smit JWA, The European Thyroid Association Task Force (2012) 2012 European Thyroid Association guidelines for metastatic medullary thyroid cancer. Eur Thyroid J 1:5–14. doi:10.1056/NEJMoa1108586
Duntas LH (2013) Clinical comments related to medullary thyroid cancer diagnosis and management. Thyroid Res 6(Suppl 1):S6. doi:10.1186/1756-6614-6-S1-S6
Yen TW, Shapiro SE, Gagel RF, Sherman SI, Lee JE, Evans DB (2003) Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. Surgery 134:890–899
Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229:880–887
Roh JL, Park JY, Park CI (2007) Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 245:604–610
Wong KP, Lang BH (2011) The role of prophylactic central neck dissection in differentiated thyroid carcinoma: issues and controversies. J Oncol 2011:127929. doi:10.1155/2011/127929
Greene FL, Page DL, Fleming ID, Fritz A, Balch DM (2003) AJCC cancer staging manual, 6th edn. Springer Verlag, Chicago
Boostrom SY, Grant CS, Thompson GB, Farley DR, Richards ML, Hoskin TL, Hay ID (2009) Need for a revised staging consensus in medullary thyroid carcinoma. Arch Surg 144:663–669. doi:10.1001/archsurg.2009.122
Gülben K, Berberoğlu U, Boyabatli M (2006) Prognostic factors for sporadic medullary thyroid carcinoma. World J Surg 30:84–90
Clark JR, Fridman TR, Odell MJ, Brierley J, Walfish PG, Freeman JL (2005) Prognostic variables and calcitonin in medullary thyroid cancer. Laryngoscope 115:1445–1450
Rendl G, Manzl M, Hitzl W, Sungler P, Pirich C (2008) Longterm prognosis of medullary thyroid carcinoma. Clin Endocrinol 69:497–505. doi:10.1111/j.1365-2265.2008.03229.x
Hyer SL, Vini L, A’Hern R, Harmer C (2000) Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival. Eur J Surg Oncol 26:686–690
Dottorini ME, Assi A, Sironi M, Sangalli G, Spreafico G, Colombo L (1996) Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables. Cancer 77:1556–1565
Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH (2000) Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88:1139–1148
Ito Y, Miyauchi A, Yabuta T, Fukushima M, Inoue H, Tomoda C, Uruno T, Kihara M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F (2009) Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution. World J Surg 33:58–66. doi:10.1007/s00268-008-9795-2
de Groot JW, Plukker JT, Wolffenbuttel BH, Wiggers T, Sluiter WJ, Links TP (2006) Determinants of life expectancy in medullary thyroid cancer: age does not matter. Clin Endocrinol (Oxf) 65:729–736
O’Riordain DS, O’Brien T, Weaver AL, Gharib H, Hay ID, Grant CS, van Heerden JA (1994) Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery 116:1017–1023
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study received no financial support. For this type of study, formal consent is not required. All the procedures related to the study were approved by the local ethics committee of the hospital.
Conflict of Interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Vlad, M., Zosin, I., Timar, B. et al. Results of Surgical Therapy in Patients with Medullary Thyroid Carcinoma. Indian J Surg 78, 309–314 (2016). https://doi.org/10.1007/s12262-015-1386-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-015-1386-5